Simcere Pharmaceutical Group Limited
2096
Clasificación en acciones
#4476
Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the... Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the comprehensive process of discovering, developing, manufacturing, and commercializing pharmaceutical products. These medicines are distributed to various clients, including distributors, pharmacy chains, and fellow drug manufacturers within China. The company strategically focuses on a diverse range of therapeutic areas, notably oncology, central nervous system conditions, autoimmune diseases, anti-infective treatments, and cardiovascular health, among others. Its extensive product portfolio features key medications such as Sanbexin (an edaravone and dexborneol concentrated solution for injection), Endostar (a recombinant human endostatin injection), ENWEIDA (an envafolimab injection), Softan (rosuvastatin calcium tablets), ZAILIN (amoxicillin in granules, dispersible tablets, or capsules), Iremod (iguratimod tablets), Antine (diclofenac sodium sustained-release capsules or gel), and Orencia (an abatacept injection). Additionally, Simcere offers specialized promotional services for pharmaceutical goods. Demonstrating its commitment to innovation, the group has established a strategic regional licensing collaboration with Vivoryon Therapeutics N.V. This partnership aims to develop and commercialize novel therapies for Alzheimer's disease by targeting the neurotoxic amyloid protein N3pE (pGlu-Aß). Established in 1995, Simcere Pharmaceutical Group Limited is headquartered in Nanjing, China.
Precio por acción
$1.32
Capitalización bursátil
$3.40B
Cambio (1 día)
-4.51%
Cambio (1 año)
-19.88%
País
CN
Comercio Simcere Pharmaceutical Group Limited (2096)
Categoría
Healthcare
Historial de dividendos de Simcere Pharmaceutical Group Limited (2096)
Simcere Pharmaceutical Group Limited (símbolo bursátil: 2096) realizó un total de 6 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: $1.09
Rentabilidad por dividendo (TTM): 0.0199
La suma de todos los dividendos (ajustados por splits de acciones) es: $1.09
Rentabilidad por dividendo (TTM): 0.0199
Pagos de dividendos de Simcere Pharmaceutical Group Limited (2096) desde 2021 hasta 2026
Pagos anuales de dividendos
| Año | Dividendo (ajustado por splits de acciones) | Cambiar |
|---|---|---|
| 2026 (TTM) | $0.2069 | 18.36% |
| 2025 | $0.1748 | -0.51% |
| 2024 | $0.1757 | -0.06% |
| 2023 | $0.1758 | 0.06% |
| 2022 | $0.1757 | -2.55% |
| 2021 | $0.1803 | 0.00% |
Lista de todos los pagos de dividendos
| Año | Dividendo | Cambiar |
|---|---|---|
| 2026 (TTM) | $0.2069 | 18.36% |
| 2025 | $0.1748 | -0.51% |
| 2024 | $0.1757 | -0.06% |
| 2023 | $0.1758 | 0.06% |
| 2022 | $0.1757 | -2.55% |
| 2021 | $0.1803 | 0.00% |
Pagos de dividendos de empresas similares o competidoras
| Empresa | Número de pagos de dividendos | País |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 0.00% |
NL
|
|
| 30.00% |
BE
|
